Harbourvest Partners’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.28M | Sell |
|
|||||
|
2023
Q1 | $689K | Hold |
|
|||||
|
2022
Q4 | $259K | Hold |
|
|||||
|
2022
Q3 | $374K | Hold |
|
|||||
|
2022
Q2 | $615K | Hold |
|
|||||
|
2022
Q1 | $1.09M | Hold |
|
|||||
|
2021
Q4 | $2.04M | Hold |
|
|||||
|
2021
Q3 | $4.18M | Hold |
|
|||||
|
2021
Q2 | $7.95M | Hold |
|
|||||
|
2021
Q1 | $16.6M | Hold |
|
|||||
|
2020
Q4 | $35.6M | Buy |
|